Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Fusion of cells
Reexamination Certificate
2006-08-29
2006-08-29
Ketter, James (Department: 1636)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Fusion of cells
C435S458000, C514S04400A
Reexamination Certificate
active
07098030
ABSTRACT:
An polyampholyte is utilized in a condensed polynucleotide complex for purposes of nucleic acid delivery to a cell. The complex can be formed with an appropriate amount of positive and/or negative charge such that the resulting complex can be delivered to the extravascular space and may be further delivered to a cell.
REFERENCES:
patent: 6383811 (2002-05-01), Wolff et al.
patent: 6627616 (2003-09-01), Monahan et al.
patent: 6794189 (2004-09-01), Wolff et al.
patent: 6867196 (2005-03-01), Wolff et al.
Asayama et al., “Synthesis of Novel Polyampholyte Comb-Type Copolymers Consisting of a Poly(L-lysine) Backbone and Hyaluronic Acid Side Chains for a DNA Carrier.” Bioconjugate Chem 1998 vol. 9, No. 4; pp. 476-481.
Dash PR et al. “Factors Affecting Blood Clearance and In Vivo Distribution of Polyelectrolyte Complexes for Gene Delivery.” Gene Therapy; 1999; vol. 6, pp. 643-650.
Elbashir et al. “Duplexes of 21-nucleotide RNAs mediate RNA interferencein cultured mammalian cells.” Nature 2001 vol. 411 p. 494-498.
Murthy et al. “The Design and Synthesis of Polymers for Eukaryotic Membrane Disruption.” Journal of Controlled Release; 1999; vol. 61; pp. 137-143.
Naganawa et al. “Synthetic Studies on Tautamycin synthesis of 2,3-disubstituted maleic anhydride segment.” Tetrahedron 1994 vol. 50 No. 30 p. 8969-8982.
Netz R et al. “Complexation Behavior of Polyampholytes and Charged Objects.” Macromolecules; 1998; vol. 51; pp. 5123-5141.
Ogris M et al. “PEGylated DNA/Transferrin-PEI Complexes: Reduced Interaction with Blood Components, Extended Circulation in Blood and Potential for Systemic Gene Delivery.” Gene Therapy; 1996; vol. 6; pp. 595-605.
Plank C et al. “Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene Delivery.” Human Gene Therapy; Aug. 1, 1996; vol. 7; pp. 1437-1446.
Ross PC et al. “Lipoplex Size is a Major Determinant of In Vitro Lipofection Efficiency.” Gene Therapy; 1999; vol. 6; pp. 651-659.
Sharp “RNA Interference-2001” Genes & Development 2001 vol. 15 p. 485-490.
Trubetskoy VS et al. “Layer-by-Layer Deposition of Oppositely Charged Polyelectrolytes on the Surface of Condensed DNA Particles.” Nucleic Acids Research; 1999; vol. 27, No. 15; pp. 3090-3095.
Tushcl et al. “Targeted mRNA degradation by double-stranded RNA in vitro.” Genes & Development 1999 vol. 13 p. 3191-3197.
Vitiello L et al. “Transfection of Cultured Myoblasts in High Serum Concentration with DODAC:DOPE Liposomes.” Gene Therapy; 1998; vol. 5; pp. 1306-1313.
Wolfert MA et al. “Characterization of Vectors for Gene Therapy Formed by Self-Assembly of DNA with Synthetic Block Co-Polymers.” Human Gene Therapy; Nov. 10, 1996; vol. 7; pp. 2123-2133.
Xu Y et al. “Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection.” Biochemistry; 1996; vol. 35, pp. 5616-5623.
Budker Vladimir G.
Hagstrom James E.
Monahan Sean D.
Rozema David B.
Slattum Paul M.
Ekena Kirk
Johnson Mark K.
Ketter James
Mirus Bio Corporation
LandOfFree
Polyampholytes for delivering polyions to a cell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyampholytes for delivering polyions to a cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyampholytes for delivering polyions to a cell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3659824